Vimarsana
Biggest News Aggregation in the World

Page 31 - Patrick Wingrove News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Patrick Wingrove. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Patrick Wingrove Today - Breaking & Trending Today

Analysis-Launch of arthritis drug biosimilars ramps up US pressure on pricing 'middlemen' - Vimarsana News

Analysis-Launch of arthritis drug biosimilars ramps up US pressure on pricing 'middlemen'

Cheaper versions of one of the most costly and widely used arthritis treatments in the U.S. are likely to fuel further scrutiny of the middlemen that negotiate drug prices for most insured...

J&J upbeat on 2023 as devices rebound post-COVID, shares jump - Vimarsana News

J&J upbeat on 2023 as devices rebound post-COVID, shares jump

Johnson & Johnson on Thursday expressed optimism for strong growth this year, saying it expected to surpass profit estimates with joint replacement and other surgeries rebounding after COVID-19 and...

Delays Getting Higher Dose Wegovy to Patients - Vimarsana News

Delays Getting Higher Dose Wegovy to Patients

Some US patients taking the two highest doses of Novo Nordisk's Wegovy weight-loss drug are facing difficulty filling their prescriptions, suggesting a new supply challenge for the popular medicine.

Delays getting higher dose Wegovy to patients reported by US doctors - Vimarsana News

Delays getting higher dose Wegovy to patients reported by US doctors

Some U.S. patients taking the two highest doses of Novo Nordisk's Wegovy weight-loss drug are facing difficulty filling their prescriptions, eight doctors around the country told Reuters this week,...

Exclusive: Delays getting higher dose Wegovy to patients reported by US doctors - Vimarsana News

Exclusive: Delays getting higher dose Wegovy to patients reported by US doctors

Some U.S. patients taking the two highest doses of Novo Nordisk's Wegovy weight-loss drug are facing difficulty filling their prescriptions, eight doctors around the country told Reuters this week, suggesting a new supply challenge for the popular medicine.